Press "Enter" to skip to content

New patent expiration for Biocryst drug RAPIVAB

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Biocryst drug RAPIVAB

Annual Drug Patent Expirations for RAPIVAB
Annual Drug Patent Expirations for RAPIVAB

Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has fifty-four patent family members in twenty-seven countries.

The generic ingredient in RAPIVAB is peramivir. One supplier is listed for this compound. Additional details are available on the peramivir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Biocryst drug RAPIVAB
Do NOT follow this link or you will be banned from the site!